Your browser doesn't support javascript.
loading
Author Correction: Guidelines and definitions for research on epithelial-mesenchymal transition.
Yang, Jing; Antin, Parker; Berx, Geert; Blanpain, Cédric; Brabletz, Thomas; Bronner, Marianne; Campbell, Kyra; Cano, Amparo; Casanova, Jordi; Christofori, Gerhard; Dedhar, Shoukat; Derynck, Rik; Ford, Heide L; Fuxe, Jonas; García de Herreros, Antonio; Goodall, Gregory J; Hadjantonakis, Anna-Katerina; Huang, Ruby Y J; Kalcheim, Chaya; Kalluri, Raghu; Kang, Yibin; Khew-Goodall, Yeesim; Levine, Herbert; Liu, Jinsong; Longmore, Gregory D; Mani, Sendurai A; Massagué, Joan; Mayor, Roberto; McClay, David; Mostov, Keith E; Newgreen, Donald F; Nieto, M Angela; Puisieux, Alain; Runyan, Raymond; Savagner, Pierre; Stanger, Ben; Stemmler, Marc P; Takahashi, Yoshiko; Takeichi, Masatoshi; Theveneau, Eric; Thiery, Jean Paul; Thompson, Erik W; Weinberg, Robert A; Williams, Elizabeth D; Xing, Jianhua; Zhou, Binhua P; Sheng, Guojun.
Affiliation
  • Yang J; Departments of Pharmacology and Pediatrics, Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA. jingyang@ucsd.edu.
  • Antin P; Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, USA.
  • Berx G; Molecular and Cellular Oncology Lab, Department of Biomedical Molecular Biology, Ghent University, Cancer Research Institute Ghent (CRIG), VIB Center for Inflammation Research, Ghent, Belgium.
  • Blanpain C; Laboratory of Stem Cells and Cancer, Université Libre de Bruxelles, Bruxelles, Belgium.
  • Brabletz T; Department of Experimental Medicine 1, Nikolaus-Fiebiger-Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
  • Bronner M; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
  • Campbell K; Department of Biomedical Science and Bateson Centre, University of Sheffield, Sheffield, UK.
  • Cano A; Departamento de Bioquímica, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols' (CSIC-UAM), IdiPAZ & Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Casanova J; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology/Institut de Biologia Molecular de Barcelona (IBMB-CSIC), Barcelona, Spain.
  • Christofori G; Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Dedhar S; Department of Biochemistry and Molecular Biology, University of British Columbia and British Columbia Cancer Research Centre, Vancouver, BC, Canada.
  • Derynck R; Departments of Cell and Tissue Biology, and Anatomy, University of California at San Francisco, San Francisco, CA, USA.
  • Ford HL; Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Fuxe J; Department of Laboratory Medicine (LABMED), Division of Pathology, Karolinska University Hospital and Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden.
  • García de Herreros A; Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM) and Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain.
  • Goodall GJ; Centre for Cancer Biology, An alliance of SA Pathology and University of South Australia, Adelaide, SA, Australia.
  • Hadjantonakis AK; Developmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Huang RYJ; School of Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Kalcheim C; Department of Medical Neurobiology, Institute for medical Research Israel-Canada and the Safra Center for Neurosciences, Hebrew University of Jerusalem, Hadassah Medical School, Jerusalem, Israel.
  • Kalluri R; Department of Cancer Biology, Metastasis Research Center, MD Anderson Cancer Center, Houston, TX, USA.
  • Kang Y; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
  • Khew-Goodall Y; Centre for Cancer Biology, an Alliance of SA Pathology and the University of South Australia, Adelaide, SA, Australia.
  • Levine H; Department of Physics, Northeastern University, Boston, MA, USA.
  • Liu J; Department of Anatomic Pathology, The Division of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Longmore GD; Department of Medicine (Oncology) and Department of Cell Biology and Physiology, ICCE Institute, Washington University, St. Louis, MO, USA.
  • Mani SA; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Massagué J; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Mayor R; Department of Cell and Developmental Biology, University College London, London, UK.
  • McClay D; Department of Biology, Duke University, Durham, NC, USA.
  • Mostov KE; Departments of Anatomy and Biochemistry/Biophysics, University of California, San Francisco, School of Medicine, San Francisco, CA, USA.
  • Newgreen DF; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC, Australia.
  • Nieto MA; Instituto de Neurociencias (CSIC-UMH) Avda Ramon y Cajal s/n, Sant Joan d´Alacant, Spain.
  • Puisieux A; Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.
  • Runyan R; Institut Curie, PSL Research University, Paris, France.
  • Savagner P; Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, USA.
  • Stanger B; INSERM UMR 1186, Integrative Tumor Immunology and Genetic Oncology, Gustave Roussy, University Paris-Saclay, Villejuif, France.
  • Stemmler MP; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Takahashi Y; Department of Experimental Medicine 1, Nikolaus-Fiebiger-Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
  • Takeichi M; Department of Zoology, Graduate School of Science, Kyoto University, Kyoto, Japan.
  • Theveneau E; RIKEN Center for Biosystems Dynamics Research, Kobe, Japan.
  • Thiery JP; Centre de Biologie du Développement (CBD), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, Toulouse, France.
  • Thompson EW; Guangzhou Regenerative Medicine and Health, Guangdong Laboratory, Guangzhou, China.
  • Weinberg RA; School of Biomedical Sciences and Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Woolloongabba, QLD, Australia.
  • Williams ED; Whitehead Institute for Biomedical Research, Department of Biology, MIT Ludwig Center for Molecular Oncology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Xing J; Australian Prostate Cancer Research Centre-Queensland (APCRC-Q) and Queensland Bladder Cancer Initiative (QBCI), School of Biomedical Sciences and Institute of Health and Biomedical Innovation, Queensland University of Technology, Woolloongabba, QLD, Australia.
  • Zhou BP; Department of Computational and Systems Biology and UPMC-Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • Sheng G; Department of Molecular and Cellular Biochemistry and UK Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY, USA.
Nat Rev Mol Cell Biol ; 22(12): 834, 2021 Dec.
Article in En | MEDLINE | ID: mdl-34654908

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Nat Rev Mol Cell Biol Journal subject: BIOLOGIA MOLECULAR Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Nat Rev Mol Cell Biol Journal subject: BIOLOGIA MOLECULAR Year: 2021 Document type: Article Affiliation country: